Meta stabilises at $621 but the cost story hasn't changed
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Meta Platforms has clawed back some ground after last week's post-earnings selloff, but the fundamental tension that drove the stock from $777 to $612 in a month remains unresolved: a revenue machine that still works, wrapped in a cost structure that now absorbs most of the gains.
Shares closed at $621, up 2.4% on the day and essentially flat on the week. The one-month picture is still ugly, down 14.7%. That puts the stock roughly $227 below the consensus analyst mean target of $848. The gap is not new, but it has widened rather than closed since the Q3 print landed on October 28. What is new this week is the absence of a fresh catalyst in either direction, which makes the positioning data the most useful read available.
Options traders are not particularly alarmed. The put/call ratio has drifted slightly lower to 0.49, fractionally below its 20-day average of 0.50 and well away from the 52-week high of 0.70. The z-score of minus 0.77 means hedging demand is marginally below normal, not elevated. For a stock that has lost 15% in a month and faces a $175 billion to $179 billion operating expense guidance for 2026, the absence of defensive options positioning is itself a signal: buyers are not racing to protect against further downside, and the lending market tells the same story. Availability is effectively unlimited, with over 1.5 billion shares available to borrow against roughly 29 million shares short. Cost to borrow has fallen 32% over the past week to 0.27%. Short interest at 1.3% of the float is structurally low enough to be irrelevant as a directional signal, though it has crept up 2% week-on-week, consistent with a small number of new bears being drawn in by the price weakness.
The Street is holding its bullish position despite the earnings reaction. All the analyst target increases reported on October 22 remain in place, with no downgrades since the print. Bulls point to 3.64 billion daily active users, 26% revenue growth, and AI-powered ad pricing that lifted average prices 14% in Q3. Nearly 10 million advertisers already use Meta's generative AI tools, and the Muse hardware product accumulated more than 10 million setups in its first six weeks, with daily usage above 25% and early shopping activity averaging over $200 per purchase. The bear case centres squarely on cost. Free cash flow turned negative in Q3. Full-year 2026 opex guidance of $175 billion to $179 billion implies roughly 50% year-on-year cost growth at the midpoint. The new Class C share structure, effective January 19, 2027, is read by sceptics as flagging a potential equity issuance. The trailing PE has contracted to 17.9 from above 21 a month ago, and the price-to-book has fallen to 4.4. Those are lower multiples than Meta has carried for most of the past two years, which is why analysts rank the stock in the 97th percentile on analyst recommendation divergence, a wide gap between the Street's bullish consensus and what the market is currently willing to pay.
Wikipedia page views offer a small data point worth noting. ORTEX's retail attention signal, combining English Wikipedia views and ORTEX stock page traffic, hit a 90-day z-score of 2.78 as of October 23, a level last reached around the Q3 earnings convergence spike. The signal has since moderated as the event passed. None of the five alt data datasets covering Meta carry a measured lead against its reported financials, so the Wikipedia data describes attention, not revenue trajectory.
Among peers, GOOGL dropped 12.6% on the week while RDDT fell 29.5% and ZH lost 23%. Meta's near-flat week looks considerably more stable against that backdrop. NXDR gained 4% on the day, a divergence that suggests sector-level selling pressure eased rather than any Meta-specific recovery story.
The next earnings event is scheduled for January 27, 2027, 84 days away. Between now and then, the stock's direction is likely to be shaped by whether the Q4 cost trajectory matches or exceeds the elevated guidance, and whether the Muse product's early engagement metrics translate into a meaningful revenue line. Those are the numbers worth tracking at the next print.
Stocks in this article
See the live data behind this article on ORTEX.
Open META on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 19:45
- Data as of
- 4 Nov 2026, 19:44
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.